TNPO3: A Potential Drug Target and Biomarker (G23534)

Target Name: TNPO3

NCBI ID: G23534

TNPO3

TNPO3: A Potential Drug Target and Biomarker

Tumor necrosis factor-alpha (TNF-alpha) is a cytokine that plays a crucial role in the immune response and has been implicated in various diseases, including cancer. TNPO3 is a specific cytokine that has been identified as a potential drug target and biomarker for various diseases, including cancer.

The TNPO3 gene has not yet been fully characterized, but its function in the immune response is well established. TNPO3 is a 21-kDa cytokine that is expressed in various tissues, including blood cells, organs, and tissues. It has been shown to play a role in the regulation of immune cell function, including the activation and proliferation of natural killer cells, T-cells, and B-cells.

One of the key functions of TNPO3 is its role in the regulation of apoptosis, which is the process by which cells undergo programmed cell death. TNPO3 has been shown to induce apoptosis in various cell types, including cancer cells, which may be a potential mechanism by which it can be used as a drug.

Another function of TNPO3 is its role in the regulation of inflammation. TNPO3 has been shown to have anti-inflammatory effects and to regulate the production of pro-inflammatory cytokines. This may be important for its potential use in diseases that are characterized by chronic inflammation, such as cancer.

TNPO3 has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-beta pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

In conclusion, TNPO3 is a promising drug target and biomarker for a variety of diseases, including cancer. Its functions in the regulation of immune cell function, apoptosis, inflammation, and cellular signaling pathways make it a promising candidate for development as a new drug. Further research is needed to fully understand the potential mechanisms of TNPO3 and its potential as a drug.

Protein Name: Transportin 3

Functions: Importin, which transports target proteins into the nucleus (PubMed:10366588, PubMed:10713112, PubMed:11517331, PubMed:12628928, PubMed:24449914). Specifically mediates the nuclear import of splicing factor serine/arginine (SR) proteins, such as RBM4, SFRS1 and SFRS2, by recognizing phosphorylated SR domains (PubMed:10366588, PubMed:10713112, PubMed:11517331, PubMed:12628928, PubMed:24449914). Also mediates the nuclear import of serine/arginine (SR) protein CPSF6, independently of CPSF6 phosphorylation (PubMed:30916345, PubMed:31465518). The nuclear import process is regulated by the small GTPase Ran that partitions between cytoplasm and nucleus in the predominantly GDP- and GTP-bound form, respectively (PubMed:23878195, PubMed:24449914). Importin associates with target cargo proteins in the cytoplasm, and the competitive binding of GTP-bound Ran induces the release of cargos in the nucleus (PubMed:23878195, PubMed:24449914)

The "TNPO3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TNPO3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets